| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
ChromoGenics AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr7.22 |
| 52 Week High | kr21.00 |
| 52 Week Low | kr3.86 |
| Beta | 0.98 |
| 1 Month Change | 8.73% |
| 3 Month Change | -15.06% |
| 1 Year Change | -65.29% |
| 3 Year Change | -99.13% |
| 5 Year Change | -99.92% |
| Change since IPO | -99.99% |
Recent News & Updates
Shareholder Returns
| CHRO | SE Building | SE Market | |
|---|---|---|---|
| 7D | 2.8% | -0.8% | -1.7% |
| 1Y | -65.3% | -9.6% | 8.1% |
Return vs Industry: CHRO underperformed the Swedish Building industry which returned -8.2% over the past year.
Return vs Market: CHRO underperformed the Swedish Market which returned 8.8% over the past year.
Price Volatility
| CHRO volatility | |
|---|---|
| CHRO Average Weekly Movement | 12.3% |
| Building Industry Average Movement | 4.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 13.0% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: CHRO's share price has been volatile over the past 3 months.
Volatility Over Time: CHRO's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 33 | Fredrik Franding | www.chromogenics.com |
ChromoGenics AB provides glass products in Sweden. It offers dynamic and static glasses, and colored solar facades under the ConverLight name. The company was incorporated in 2002 and is headquartered in Uppsala, Sweden.
ChromoGenics AB Fundamentals Summary
| CHRO fundamental statistics | |
|---|---|
| Market cap | kr47.87m |
| Earnings (TTM) | -kr52.51m |
| Revenue (TTM) | kr15.70m |
3.0x
P/S Ratio-0.9x
P/E RatioIs CHRO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHRO income statement (TTM) | |
|---|---|
| Revenue | kr15.70m |
| Cost of Revenue | kr8.62m |
| Gross Profit | kr7.08m |
| Other Expenses | kr59.58m |
| Earnings | -kr52.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 23, 2024
| Earnings per share (EPS) | -7.92 |
| Gross Margin | 45.08% |
| Net Profit Margin | -334.39% |
| Debt/Equity Ratio | 156.3% |
How did CHRO perform over the long term?
See historical performance and comparison